AI-based multiparametric imaging of glioblastoma for a personalised treatment strategy
Glioblastoma is the most frequent and aggressive malignant tumour of the central nervous system. Tumour heterogeneity is the major factor responsible for the disease's high mortality rate and resistance to effective treatment. The EU-funded GLIOHAB project will develop an artificial intelligence-based system with the ability to monitor the functional state of the glioblastoma at pixel level. The development of the software capitalises on technologies previously co-developed, validated and patented by the project researcher. GLIOHAB represents a multidisciplinary effort of the best experts to provide the optimum conditions for a holistic approach to glioblastoma treatment.
Fields of science
Call for proposal
See other projects for this call